Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques

Author： Nuijten M.J.C.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.12, 2002-01, pp. : 855-867

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA

By Silverberg K   Schertz J   Falk B   Beresniak A  

Reproductive BioMedicine Online, Vol. 5, Iss. 3, 2002-11 ,pp. : 265-269

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes

By Baio Gianluca   Russo Pierluigi  

PharmacoEconomics, Vol. 27, Iss. 8, 2009-08 ,pp. : 645-655

Adis International

Access to resources Recommend Favorite

Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis

By Boersma Cornelis   Broere Adriaan   Postma Maarten J.  

Value in Health, Vol. 13, Iss. 6, 2010-09 ,pp. : 853-856

Blackwell Publishing

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite